Diagnostic Revision From Primary Lateral Sclerosis to Amyotrophic Lateral Sclerosis

Read full text
Authors: Eva Maria Johanna de Boer, Sean W. Willemse, Jan H. Veldink, H. Stephan Goedee, Alexander F. J. E. Vrancken, Wouter van Rheenen, Henk‐Jan Westeneng, Leonard H. van den Berg, Michael A. van Es
Cited by: 1
References: 35

Abstract

BACKGROUND AND OBJECTIVES: Primary lateral sclerosis (PLS) is defined as a pure upper motor neuron syndrome and is a diagnosis of exclusion, amyotrophic lateral sclerosis (ALS) being the most likely alternative diagnostic consideration. A minimum disease duration of 2 years is required for the diagnosis of PLS, after which patients are classified as probable PLS (P-PLS) and subsequently as definite PLS (D-PLS) after 4 years. Our aim is to apply the current diagnostic criteria to a population-based cohort and investigate which clinical characteristics are associated with a diagnostic revision to ALS. METHODS: This cohort study included patients meeting the current diagnostic criteria for PLS retrospectively from the Dutch Motor Neuron Disease Registry. Diagnostic revision to ALS was based on clinical assessment, EMG findings according to the revised El Escorial Criteria, or if patients had died from disease progression within 4 years of disease onset. Clinical characteristics were compared for patients who underwent diagnostic revision with ALS vs true PLS. Subdistribution hazard ratios (SHRs) for characteristics associated with diagnostic revision were determined using Fine-Gray regression. RESULTS: ). DISCUSSION: In our cohort, most diagnostic revisions from PLS to ALS were in patients with a disease duration of less than 4 years. Besides disease duration, a faster progression rate was associated with diagnostic revision from PLS to ALS. Adding progression rate to the current diagnostic criteria could increase accuracy and help identify patients at higher risk of developing ALS.

Fields of Study & Subjects

Amyotrophic Lateral Sclerosis Research Parkinson's Disease and Spinal Disorders Glycogen Storage Diseases and Myoclonus

Publication details

Journal / source
Neurology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
106
Issue
12
Pages
e218055–e218055
Publication date
29 May 2026
Language
EN